Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Brain Neoplasms × Filgrastim × 30 days × Clear all

Sponsor

Conditions

Precursor Cell Lymphoblastic Leukemia-Lymphoma 8 Leukemia, Myeloid, Acute 8 Leukemia, Biphenotypic, Acute 5 Hodgkin Disease 5 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 4 Myelodysplastic Syndromes 4 Burkitt Lymphoma 4 Leukemia, Myelogenous, Chronic, BCR-ABL Positive 3 Neoplasms 2 Leukemia, Myelomonocytic, Chronic 2 Leukemia 2 Hematologic Neoplasms 2 Breast Neoplasms 2 Teratoma 1 Sarcoma, Ewing 1 Sarcoma 1 Rhabdomyosarcoma 1 Recurrence 1 Osteosarcoma 1 Multi-centric Castleman's Disease 1 Macular dystrophy, corneal type 1 1 Lymphoproliferative Disorders 1 Lymphoma, T-Cell, Cutaneous 1 Lymphoma, Non-Hodgkin 1 Lymphoma, Mantle-Cell 1 Lymphoma, Large-Cell, Anaplastic 1 Lymphoma, Large B-Cell, Diffuse 1 Lymphoma, Follicular 1 Lymphoma, B-Cell, Marginal Zone 1 Lymphoma 1

Interventions

Radiosurgery 11 Magnetic Resonance Spectroscopy 8 Temozolomide 6 Bevacizumab 6 Specimen Handling 5 trastuzumab deruxtecan 4 pembrolizumab 4 Radiotherapy 4 Cyclophosphamide 4 Biopsy 4 abemaciclib 3 Nivolumab 3 entrectinib 2 Trastuzumab 2 Surveys and Questionnaires 2 Surgical Procedures, Operative 2 Sirolimus 2 Receptors, Interleukin-8B 2 Mental Status and Dementia Tests 2 Ipilimumab 2 Granulocyte-Macrophage Colony-Stimulating Factor 2 Dexamethasone 2 Adrenal Cortex Hormones 2 trastuzumab biosimilar HLX02 1 temsirolimus 1 ribociclib 1 repotrectinib 1 regorafenib 1 pertuzumab 1 patritumab deruxtecan 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡